Concepedia

Author

Jolanta Konieczny

Maj Institute of PharmacologyORCID

Also Known As

J KONIECZNY, J Konieczny, J. Konieczny, Jolanta Konieczny, Konieczny Jolanta

82

Publications

1.2K

Citations

22

H-Index

50

Concepts

All Affiliations

Maj Institute of PharmacologyPolish Academy of SciencesMedical University of SilesiaInstitute of PharmacologyFreie Universität Berlin
JK

About

Jolanta Konieczny is an author at Maj Institute of Pharmacology specializing in medicine, neuroscience, and neuropharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

28

947

2

Social Sciences

11

13

344

3

Health Sciences

7

7

219

4

Applied Physiology

1

1

11

5

Biochemistry

1

1

26

Jolanta Konieczny

×

31

Publications

1K

Citations

19

H-Index

YearCitations

Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats

Krystyna Ossowska, Jolanta Konieczny, S. Wolfarth,

Neuropharmacology

2001

117

SCH 58261, an A<sub>2A</sub> adenosine receptor antagonist, counteracts parkinsonian‐like muscle rigidity in rats

Jadwiga Wardas, Jolanta Konieczny, Elżbieta Lorenc‐Koci

Synapse

2001

107

LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats

Jolanta Konieczny, Krystyna Ossowska, S. Wolfarth,

Naunyn-Schmiedeberg s Archives of Pharmacology

1998

96

Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats

Katarzyna Kuter, Maria Śmiałowska, Joanna M. Wierońska,

Brain Research

2007

78

Depressive-like neurochemical and behavioral markers of Parkinson’s disease after 6-OHDA administered unilaterally to the rat medial forebrain bundle

Kinga Kamińska, Tomasz Lenda, Jolanta Konieczny,

Pharmacological Reports

2017

53

MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats

Krystyna Ossowska, Jolanta Konieczny, S. Wolfarth,

Neuropharmacology

2005

51

Lack of Neuroprotective Effect of Celastrol Under Conditions of Proteasome Inhibition by Lactacystin in In Vitro and In Vivo Studies: Implications for Parkinson’s Disease

Jolanta Konieczny, Danuta Jantas, Tomasz Lenda,

Neurotoxicity Research

2014

42

The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats

Jolanta Konieczny, Jadwiga Wardas, Katarzyna Kuter,

Neuroscience

2007

41

Influence of 6-hydroxydopamine lesion of the dopaminergic nigrostriatal pathway on the muscle tone and electromyographic activity measured during passive movements

S. Wolfarth, Jolanta Konieczny, Maria Śmiałowska,

Neuroscience

1996

36

Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson's disease in rats

Elżbieta Lorenc‐Koci, Tomasz Lenda, Lucyna Antkiewicz‐Michaluk,

Neurochemistry International

2011

33

Page 1